PTC Therapeutics (NASDAQ: PTCT) is paring some gains related ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions Rumors Trader Talk

BioMarin Pharma (BMRN) Tops Q4 EPS by 12cFebruary 25, 2015 4:04 PM PTC Therapeutics (PTCT) Buy Rating Maintained at Deutsche Bank February 24, 2015 9:57 AM PTC Therapeutics (PTCT) PT Raised to $100 at Credit Suisse Ahead of Data and/or Potential TakeoverFebruary 24, 2015 8:30 AM UPDATE: PTC Therapeutics (PTCT) pops; said to be exploring possible sale - ReutersFebruary 23, 2015 12:03 PM